107 related articles for article (PubMed ID: 37634661)
1. Absence of toll-like receptor 7 ameliorates survival and reduces intestinal injury in mice after Clostridium difficile infection.
Yu R; Yang Z; Liu J; Bai H; Ding H; Xu H; Yu H; Cao J; Lai X
Microbes Infect; 2023; 25(8):105210. PubMed ID: 37634661
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile-induced colitis in mice is independent of leukotrienes.
Trindade BC; Theriot CM; Leslie JL; Carlson PE; Bergin IL; Peters-Golden M; Young VB; Aronoff DM
Anaerobe; 2014 Dec; 30():90-8. PubMed ID: 25230329
[TBL] [Abstract][Full Text] [Related]
3. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis.
Jarchum I; Liu M; Lipuma L; Pamer EG
Infect Immun; 2011 Apr; 79(4):1498-503. PubMed ID: 21245274
[TBL] [Abstract][Full Text] [Related]
5. IL-27/IL-27 Receptor Signaling Provides Protection in Clostridium difficile-Induced Colitis.
Wang L; Cao J; Li C; Zhang L
J Infect Dis; 2018 Jan; 217(2):198-207. PubMed ID: 29140433
[TBL] [Abstract][Full Text] [Related]
6. Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection.
Peritore-Galve FC; Shupe JA; Cave RJ; Childress KO; Washington MK; Kuehne SA; Lacy DB
PLoS Pathog; 2022 Feb; 18(2):e1010323. PubMed ID: 35176123
[TBL] [Abstract][Full Text] [Related]
7. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
[TBL] [Abstract][Full Text] [Related]
8. Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
Wang J; Ghali S; Xu C; Mussatto CC; Ortiz C; Lee EC; Tran DH; Jacobs JP; Lagishetty V; Faull KF; Moller T; Rossetti M; Chen X; Koon HW
Gastroenterology; 2018 May; 154(6):1737-1750. PubMed ID: 29360463
[TBL] [Abstract][Full Text] [Related]
9. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
[TBL] [Abstract][Full Text] [Related]
10. Plakoglobin and High-Mobility Group Box 1 Mediate Intestinal Epithelial Cell Apoptosis Induced by Clostridioides difficile TcdB.
Li Y; Xu W; Ren Y; Cheung HC; Huang P; Kaur G; Kuo CJ; McDonough SP; Fubini SL; Lipkin SM; Deng X; Chang YF; Huang L
mBio; 2022 Oct; 13(5):e0184922. PubMed ID: 36043787
[TBL] [Abstract][Full Text] [Related]
11. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.
El Feghaly RE; Stauber JL; Deych E; Gonzalez C; Tarr PI; Haslam DB
Clin Infect Dis; 2013 Jun; 56(12):1713-21. PubMed ID: 23487367
[TBL] [Abstract][Full Text] [Related]
12. The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.
Sun X; Hirota SA
Mol Immunol; 2015 Feb; 63(2):193-202. PubMed ID: 25242213
[TBL] [Abstract][Full Text] [Related]
13. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins.
Erickson SL; Alston L; Nieves K; Chang TKH; Mani S; Flannigan KL; Hirota SA
FASEB J; 2020 Feb; 34(2):2198-2212. PubMed ID: 31907988
[TBL] [Abstract][Full Text] [Related]
14. The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in mice.
Hing TC; Ho S; Shih DQ; Ichikawa R; Cheng M; Chen J; Chen X; Law I; Najarian R; Kelly CP; Gallo RL; Targan SR; Pothoulakis C; Koon HW
Gut; 2013 Sep; 62(9):1295-305. PubMed ID: 22760006
[TBL] [Abstract][Full Text] [Related]
15. Modulation of colonic immunometabolic responses during Clostridioides difficile infection ameliorates disease severity and inflammation.
Tubau-Juni N; Bassaganya-Riera J; Leber AJ; Alva SS; Baker R; Hontecillas R
Sci Rep; 2023 Sep; 13(1):14708. PubMed ID: 37679643
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
Warren CA; van Opstal EJ; Riggins MS; Li Y; Moore JH; Kolling GL; Guerrant RL; Hoffman PS
Antimicrob Agents Chemother; 2013 Feb; 57(2):689-96. PubMed ID: 23147742
[TBL] [Abstract][Full Text] [Related]
17. The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model.
Zhang Y; Yang Z; Gao S; Hamza T; Yfantis HG; Lipsky M; Feng H
Anaerobe; 2017 Dec; 48():249-256. PubMed ID: 29031928
[TBL] [Abstract][Full Text] [Related]
18. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
[TBL] [Abstract][Full Text] [Related]
19.
McKee HK; Kajiwara C; Yamaguchi T; Ishii Y; Shimizu N; Ohara A; Tateda K
J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33830910
[No Abstract] [Full Text] [Related]
20. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
